Market Cap 18.17M
Revenue (ttm) 0.00
Net Income (ttm) -15.55M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.16
Volume 115,400
Avg Vol 164,816
Day's Range N/A - N/A
Shares Out 4.25M
Stochastic %K 64%
Beta -0.79
Analysts Strong Sell
Price Target $29.00

Company Profile

Cingulate Inc., a biopharmaceutical company, develops pharmaceutical products for the treatment of attention deficit/hyperactivity disorder (ADHD) and anxiety in the United States. The company develops medications capable of once-daily dosing using its proprietary drug delivery platform technology, Precision Timed Release. Its drug candidates include CTx-1301 (dexmethylphenidate), which is in Phase 3 clinical trials, as well as CTx-1302 (dextroamphetamine), which is in Phase 1/2 clinical pharmac...

Industry: Biotechnology
Sector: Healthcare
Phone: 913 942 2300
Address:
1901 West 47th Place, Kansas City, United States
Duke1979
Duke1979 Jul. 4 at 5:14 PM
$XRP.X back in XRP! Gonna be a good back half of the year! $CING $ABAT
0 · Reply
ru8fru
ru8fru Jul. 2 at 6:10 PM
$CING gimme $10 here
0 · Reply
CARTE_BLANCHE_DEVEREAUX
CARTE_BLANCHE_DEVEREAUX Jul. 1 at 9:21 PM
$SLS Copied from chat.. I believe $ATHE will be a multibagger (6x) I believe $CING will be a multibagger (8x) I believe SLS will be a multibagger. (20x) I believe $PYPD will be a multi-bagger (10x) I believe RILY will be a multibagger. (4x) I believe ANRO will be a multibagger (15x) Oust will double ( or more) before I sell it. I'm up 40% on Slpd since I mentioned it in the group. And Bar may have found something with poet. My trading account is spread equally across those ... even though I believe in SLS the most. Stick and move.... Stick and move....
2 · Reply
chuckjackson
chuckjackson Jun. 27 at 10:55 PM
$CING I suspect when they file the NDA, Shane will put out a couple of youtube videos and maybe do a benzinga interview again to pump the stock to retail investors. Then they will be merciless with an offering when the stock spikes. Just be careful
1 · Reply
BullFunds
BullFunds Jun. 26 at 8:42 PM
$CING intact deep 🤣🤣😳
0 · Reply
Sam898989
Sam898989 Jun. 25 at 3:52 AM
$CING Back to the daily Chatgpt interpretations! Thanks for sharing the full Form 4. Here's a clear breakdown from a shareholder perspective—focusing on what this means for the stock and sentiment: 📄 What Happened? Insider: Peter J. Werth (a major shareholder and Director) Transaction Date: June 20, 2025 Type: Award of Stock Options Security: Option to purchase 15,000 shares of Common Stock Exercise Price: $4.14 Expiration: June 20, 2035 Cost to Insider: $0 at issuance Vesting: These options vest on the earlier of: The 1-year anniversary (June 20, 2026), or The 2026 Annual Meeting of Stockholders ✅ Positive Signals Insider Confidence: Peter Werth accepting 10-year stock options at $4.14 (close to market price) implies belief that the stock will rise substantially over time. No Selling: This is not a sale. No insider dumped shares—this was a grant, which is generally a bullish signal. Reflects alignment with shareholder value creation over time, especially with upcoming catalysts
0 · Reply
fullobullz
fullobullz Jun. 25 at 2:55 AM
$CING https://www.cingulate.com/investors/financials-filings/sec-filings
0 · Reply
DaStockman
DaStockman Jun. 24 at 9:46 PM
$CING Finished green then up again after hours, classic accumulation in play.
0 · Reply
activehybrid
activehybrid Jun. 24 at 4:59 PM
$CING 4 executives directly(option to buy) bought 15 thousands shares each at $4.14 last week Peter Werth is one of them
1 · Reply
Educated_Degenerate
Educated_Degenerate Jun. 24 at 2:15 PM
$CING where volume?
0 · Reply
Latest News on CING
Cingulate Initiates Final Study for Lead ADHD Asset CTx-1301

Sep 12, 2024, 8:30 AM EDT - 10 months ago

Cingulate Initiates Final Study for Lead ADHD Asset CTx-1301


Cingulate to Participate in Benzinga All Live Access Event

Aug 27, 2024, 4:30 PM EDT - 11 months ago

Cingulate to Participate in Benzinga All Live Access Event


Cingulate Announces Adjournment of Special Meeting

Aug 23, 2024, 4:45 PM EDT - 11 months ago

Cingulate Announces Adjournment of Special Meeting


Cingulate to Attend DCAT Week 2024 in New York City

Mar 6, 2024, 6:45 AM EST - 1 year ago

Cingulate to Attend DCAT Week 2024 in New York City


Cingulate Announces Closing of $7.5 Million Public Offering

Feb 6, 2024, 4:15 PM EST - 1 year ago

Cingulate Announces Closing of $7.5 Million Public Offering


Cingulate Announces Pricing of $7.5 Million Public Offering

Feb 2, 2024, 9:15 AM EST - 1 year ago

Cingulate Announces Pricing of $7.5 Million Public Offering


Cingulate Inc. to Present at the LD Micro Main Event XVI

Sep 21, 2023, 1:30 PM EDT - 1 year ago

Cingulate Inc. to Present at the LD Micro Main Event XVI


Cingulate Inc. To Present at the LD Micro Main Event XVI

Sep 21, 2023, 11:23 AM EDT - 1 year ago

Cingulate Inc. To Present at the LD Micro Main Event XVI


Cingulate Announces Closing of $4.0 Million Public Offering

Sep 13, 2023, 4:15 PM EDT - 1 year ago

Cingulate Announces Closing of $4.0 Million Public Offering


Cingulate Announces Pricing of $4.0 Million Public Offering

Sep 11, 2023, 9:22 AM EDT - 1 year ago

Cingulate Announces Pricing of $4.0 Million Public Offering


Cingulate to Present at 13th Annual LD Micro Invitational

May 25, 2023, 3:55 PM EDT - 2 years ago

Cingulate to Present at 13th Annual LD Micro Invitational


Duke1979
Duke1979 Jul. 4 at 5:14 PM
$XRP.X back in XRP! Gonna be a good back half of the year! $CING $ABAT
0 · Reply
ru8fru
ru8fru Jul. 2 at 6:10 PM
$CING gimme $10 here
0 · Reply
CARTE_BLANCHE_DEVEREAUX
CARTE_BLANCHE_DEVEREAUX Jul. 1 at 9:21 PM
$SLS Copied from chat.. I believe $ATHE will be a multibagger (6x) I believe $CING will be a multibagger (8x) I believe SLS will be a multibagger. (20x) I believe $PYPD will be a multi-bagger (10x) I believe RILY will be a multibagger. (4x) I believe ANRO will be a multibagger (15x) Oust will double ( or more) before I sell it. I'm up 40% on Slpd since I mentioned it in the group. And Bar may have found something with poet. My trading account is spread equally across those ... even though I believe in SLS the most. Stick and move.... Stick and move....
2 · Reply
chuckjackson
chuckjackson Jun. 27 at 10:55 PM
$CING I suspect when they file the NDA, Shane will put out a couple of youtube videos and maybe do a benzinga interview again to pump the stock to retail investors. Then they will be merciless with an offering when the stock spikes. Just be careful
1 · Reply
BullFunds
BullFunds Jun. 26 at 8:42 PM
$CING intact deep 🤣🤣😳
0 · Reply
Sam898989
Sam898989 Jun. 25 at 3:52 AM
$CING Back to the daily Chatgpt interpretations! Thanks for sharing the full Form 4. Here's a clear breakdown from a shareholder perspective—focusing on what this means for the stock and sentiment: 📄 What Happened? Insider: Peter J. Werth (a major shareholder and Director) Transaction Date: June 20, 2025 Type: Award of Stock Options Security: Option to purchase 15,000 shares of Common Stock Exercise Price: $4.14 Expiration: June 20, 2035 Cost to Insider: $0 at issuance Vesting: These options vest on the earlier of: The 1-year anniversary (June 20, 2026), or The 2026 Annual Meeting of Stockholders ✅ Positive Signals Insider Confidence: Peter Werth accepting 10-year stock options at $4.14 (close to market price) implies belief that the stock will rise substantially over time. No Selling: This is not a sale. No insider dumped shares—this was a grant, which is generally a bullish signal. Reflects alignment with shareholder value creation over time, especially with upcoming catalysts
0 · Reply
fullobullz
fullobullz Jun. 25 at 2:55 AM
$CING https://www.cingulate.com/investors/financials-filings/sec-filings
0 · Reply
DaStockman
DaStockman Jun. 24 at 9:46 PM
$CING Finished green then up again after hours, classic accumulation in play.
0 · Reply
activehybrid
activehybrid Jun. 24 at 4:59 PM
$CING 4 executives directly(option to buy) bought 15 thousands shares each at $4.14 last week Peter Werth is one of them
1 · Reply
Educated_Degenerate
Educated_Degenerate Jun. 24 at 2:15 PM
$CING where volume?
0 · Reply
VicTruth17
VicTruth17 Jun. 24 at 3:02 AM
$CING I do admit I sold off at $5.10 knowing John Fife is our cash cow… I see $3.70 to fill the gap… reload then!
1 · Reply
fullobullz
fullobullz Jun. 24 at 12:13 AM
$CING we close green tomorrow, mark it
0 · Reply
BullFunds
BullFunds Jun. 23 at 11:09 PM
$CING market maker will make sure this under buck
0 · Reply
Educated_Degenerate
Educated_Degenerate Jun. 23 at 10:44 PM
$CING eat a D
0 · Reply
BullFunds
BullFunds Jun. 23 at 3:35 PM
0 · Reply
Educated_Degenerate
Educated_Degenerate Jun. 23 at 2:40 PM
$CING in at $4.1
0 · Reply
VicTruth17
VicTruth17 Jun. 23 at 1:55 PM
$CING hmm disagree… I see two gaps from $3.70-3.99 that need filling… after this the pre NDA run and approval for PDUFA will open up a better dilution price… I’m thinking $20M valuation so $4.50 or so… then the run for the official approval… Not including any other catalyst like patent and partners
1 · Reply
BullFunds
BullFunds Jun. 20 at 3:22 PM
$CING will under $1 before its run
0 · Reply
Gps_100X_ROI_Potential
Gps_100X_ROI_Potential Jun. 19 at 10:56 PM
$SLS $ANRO $PYPD $CING $ATHE Gps will Set Records for Patient Uptake rates, with 3x 4x OS Advantages, NO Serious Side Effects, Easy Administration, ease of and low cost of Manufacture, High Margin, Fast Track, Orphan Designation, IP rights to 2035 --- CCO Est at $260K Per Patient Per Year, 25,000 AML patients /y + 75K Now in Remission who'll immediately benefit out of the Gate - BLA in H2 2025. @FireFoxF10 -- the calculations continue to increase. Just in the Last Month, we See 009 Will be efficacious for 12,000 MSI-H CRC patients each year - what do you think that is worth? and also, GPs Immunotherapy Regime has been Extended - beyond 12 months at Clinicians Requests, - more than 75% 80% of Patients will continue on Treatment - we know from the Statistically Significant P2 about half will live at least 2 years, and the CEO just disclosed at the ASM, GPs Patients surviving beyond 3 years --- the $6B GPS TAM --- now looks to be Closer to $10B Just for AML Remission. You Tell Me.
1 · Reply
Gps_100X_ROI_Potential
Gps_100X_ROI_Potential Jun. 19 at 9:38 PM
$SLS Phase 3, FDA Registrational Results - Worth Literally $10B + to Big Pharma Will BE Announced - ANY DAY NOW. GPs, an Immunotherapy for AML Remission Maintenance - 5 years in the Making and Imminent. - CEO Disclosed patients on GPs are Living 3+ Years - vs Dr's who Treat Actual P3 Control Patients Stating OS is Only 6-8 months with Best Available Treatments. Cash Runway into Q3, 2026 and More Cash Coming. This Short Manipulated equity offers the Investment Opportunity of a Lifetime. Institutional Investment up to 59 funds, 34% vs 38 funds 8% in Q3 2024 - INSIDERS PURCHASING on the Open Market - 99.9 to .01 CALL to Put Ratio. $ANRO $PYPD $CING $ATHE
0 · Reply
CARTE_BLANCHE_DEVEREAUX
CARTE_BLANCHE_DEVEREAUX Jun. 19 at 9:16 PM
$SLS Over the next few months, I'm expecting some solid moves: Riley (90% conviction for 100% gain) should pop by mid-August, $ANRO (80% conviction for 140% gain) in the next couple weeks, $ATHE (75% for 50% gain) sometime in two months, $CING (70% for 200% gain) in three, and $SLS (90% for 600% gain) in four, $PYPD (95% for 100% gain) eoy. When each one jumps, I'll cash out some profits-keeping 20% to stash in my long-term port. The rest of the gains get split between whatever plays are still active.... ignoring my 5% rule, as I'm considering this as one play. As each stock hits, the leftover money keeps cycling forward, giving me more firepower for the next move... I think each move, will be enough of a move, I only need to be right on a few of these. 50:50 shares/call splits on ANRO and SLS RILY 30/70 shares/calls. Everything else is shares only. GLTAL... eh... actually... good luck to most of you... a couple of you really suck. Bullish
4 · Reply
Babss1986
Babss1986 Jun. 19 at 10:23 AM
0 · Reply